Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Jan;75(1):75–79.

The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies

A Nicolson 1, R Appleton 1, D Chadwick 1, D Smith 1
PMCID: PMC1757463  PMID: 14707312

Abstract

Objective: To examine a large population with idiopathic generalised epilepsy (IGE), and estimate the overall remission rates for the IGEs and subsyndromes in a clinic based sample. Remission rates on valproate, lamotrigine, topiramate, and combinations of these antiepileptic drugs were estimated and factors predicting outcome examined.

Methods: All patients with IGE were identified from a computerised database and EEG records at large adult and paediatric epilepsy clinics. Data were recorded retrospectively on demographics and clinical information, seizure types and syndrome diagnosis, antiepileptic drug treatment details, and remission rates.

Results: 54.3% of 962 patients had achieved a one year period of remission; this was most likely with valproate monotherapy (52.1%), with lower rates for lamotrigine and topiramate (16.7% and 34.6%, respectively). The combination of valproate and lamotrigine achieved a remission rate of 15.3%. The factor most predictive of a response to a particular antiepileptic drug regimen was the rank order in which it was given. Relapse rate was high (79.9%) after antiepileptic drug withdrawal in remission, particularly with juvenile myoclonic epilepsy (93.6%).

Conclusions: Valproate may be the most effective antiepileptic drug in the treatment of the IGEs. Combination therapy should be initiated if an adequate trial of valproate monotherapy is not effective, rather than switching to alternative monotherapy. Antiepileptic drug treatment needs to be lifelong in many adult patients with IGE.

Full Text

The Full Text of this article is available as a PDF (208.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adab N., Jacoby A., Smith D., Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):15–21. doi: 10.1136/jnnp.70.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Annegers J. F., Hauser W. A., Elveback L. R. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 1979 Dec;20(6):729–737. doi: 10.1111/j.1528-1157.1979.tb04857.x. [DOI] [PubMed] [Google Scholar]
  3. Appleton R. E., Panayiotopoulos C. P., Acomb B. A., Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J Neurol Neurosurg Psychiatry. 1993 Dec;56(12):1312–1316. doi: 10.1136/jnnp.56.12.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biton V., Mirza W., Montouris G., Vuong A., Hammer A. E., Barrett P. S. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001 Jan 23;56(2):172–177. doi: 10.1212/wnl.56.2.172. [DOI] [PubMed] [Google Scholar]
  5. Biton V., Montouris G. D., Ritter F., Riviello J. J., Reife R., Lim P., Pledger G. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 1999 Apr 22;52(7):1330–1337. doi: 10.1212/wnl.52.7.1330. [DOI] [PubMed] [Google Scholar]
  6. Brodie M. J., Yuen A. W. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res. 1997 Mar;26(3):423–432. doi: 10.1016/s0920-1211(96)01007-8. [DOI] [PubMed] [Google Scholar]
  7. Callaghan N., O'Hare J., O'Driscoll D., O'Neill B., Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol. 1982 Dec;24(6):830–836. doi: 10.1111/j.1469-8749.1982.tb13703.x. [DOI] [PubMed] [Google Scholar]
  8. Duncan S. Polycystic ovarian syndrome in women with epilepsy: a review. Epilepsia. 2001;42 (Suppl 3):60–65. doi: 10.1046/j.1528-1157.2001.042suppl.3060.x. [DOI] [PubMed] [Google Scholar]
  9. Engel J., Jr, International League Against Epilepsy (ILAE) A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001 Jun;42(6):796–803. doi: 10.1046/j.1528-1157.2001.10401.x. [DOI] [PubMed] [Google Scholar]
  10. Hosford D. A., Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia. 1997 Apr;38(4):408–414. doi: 10.1111/j.1528-1157.1997.tb01729.x. [DOI] [PubMed] [Google Scholar]
  11. Kwan P., Brodie M. J. Early identification of refractory epilepsy. N Engl J Med. 2000 Feb 3;342(5):314–319. doi: 10.1056/NEJM200002033420503. [DOI] [PubMed] [Google Scholar]
  12. Marson Anthony G., Williamson Paula R., Clough Helen, Hutton Jane L., Chadwick David W., Epilepsy Monotherapy Trial Group Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia. 2002 May;43(5):505–513. doi: 10.1046/j.1528-1157.2002.20801.x. [DOI] [PubMed] [Google Scholar]
  13. Mattson R. H. Drug treatment of uncontrolled seizures. Epilepsy Res Suppl. 1992;5:29–35. [PubMed] [Google Scholar]
  14. Moore S. J., Turnpenny P., Quinn A., Glover S., Lloyd D. J., Montgomery T., Dean J. C. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000 Jul;37(7):489–497. doi: 10.1136/jmg.37.7.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Omtzigt J. G., Los F. J., Grobbee D. E., Pijpers L., Jahoda M. G., Brandenburg H., Stewart P. A., Gaillard H. L., Sachs E. S., Wladimiroff J. W. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology. 1992 Apr;42(4 Suppl 5):119–125. [PubMed] [Google Scholar]
  16. Sato S., White B. G., Penry J. K., Dreifuss F. E., Sackellares J. C., Kupferberg H. J. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology. 1982 Feb;32(2):157–163. doi: 10.1212/wnl.32.2.157. [DOI] [PubMed] [Google Scholar]
  17. Wilder B. J., Ramsay R. E., Murphy J. V., Karas B. J., Marquardt K., Hammond E. J. Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology. 1983 Nov;33(11):1474–1476. doi: 10.1212/wnl.33.11.1474. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES